Adrian Filiberti Selected Research

AP20187

1/2020

Loss of Osteopontin Expression Reduces HSV-1-Induced Corneal Opacity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian Filiberti Research Topics

Disease

6	Infections 06/2022 - 01/2020
6	Inflammation (Inflammations) 06/2022 - 01/2017
2	Corneal Opacity 01/2021 - 01/2020
2	Atrial Fibrillation 01/2020 - 01/2017
1	Neoplasms (Cancer) 06/2022
1	Corneal Neovascularization 10/2020
1	Obesity 04/2019
1	Necrosis 01/2019
1	Heart Failure 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Synovitis 12/2017

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 06/2022 - 01/2017
2	ChemokinesIBA 06/2022 - 10/2020
2	VaccinesIBA 01/2021 - 10/2020
2	OsteopontinIBA 01/2020 - 01/2019
1	CarcinogensIBA 06/2022
1	MutagensIBA 06/2022
1	CollagenIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Attenuated VaccinesIBA 11/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2020
1	Neutralizing AntibodiesIBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	AP20187IBA 01/2020
1	Insulin (Novolin)FDA Link 04/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2019
1	AdipokinesIBA 04/2019
1	SaltsIBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	InterleukinsIBA 01/2019

Therapy/Procedure

3	Vagus Nerve Stimulation 01/2020 - 01/2017
1	Denervation 01/2021
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2020
1	Therapeutics 01/2019